New Recruiting Trial: Multi-target TMS for Schizophrenia Negative Symptoms
WHY IT MATTERS
This trial offers a potential new treatment option for schizophrenia negative symptoms, which are often difficult to treat with current medications and significantly impact quality of life and functioning.
Researchers are testing a new brain stimulation treatment called multi-target TMS to help people with schizophrenia who experience negative symptoms — like difficulty feeling emotions, motivation, or social connection. This treatment uses magnetic pulses to stimulate specific areas of the brain. The study is now accepting patients and will take place at Shanghai Mental Health Center starting in May 2026.
NCT ID: NCT07559084 Title: Multi-target TMS for Schizophrenia Negative Symptoms Status: RECRUITING Phase: NA Sponsor: Shanghai Mental Health Center Start date: 2026-05-01 URL: https://clinicaltrials.gov/study/NCT07559084 Source: UniteRare clinical trials database
YOU CAN ACT ON THIS
If you have schizophrenia with negative symptoms, contact Shanghai Mental Health Center or visit clinicaltrials.gov/study/NCT07559084 to learn about enrollment requirements and whether you may qualify.